GLP-1 Maintenance FAQ

You hit your goal. The scale settled. Now your physician says the word "maintenance," and a quiet question shows up: what actually changes from here? Most people assume maintenance means "stop and you are done." That assumption is where a lot of frustration starts. Maintenance is its own phase, with its own rules, and it tends to confuse people more than the losing phase ever did. So let us answer the questions you are actually Googling at 11pm.

What is GLP-1 maintenance? Maintenance is the phase after active weight loss, where the goal shifts from losing more to holding what you reached. Your physician may keep your dose steady, adjust it, or discuss a longer plan. The medication is still treating a chronic condition. Individual results vary, and your plan should be reviewed in follow-up.

Maintenance is a phase, not a finish line

Maintenance is the stretch where your weight has stabilized and the work turns from losing to keeping. It is not a graduation. Obesity is treated as a chronic, relapsing condition, which means the medication is still doing a job even when the scale stops moving. Your physician decides what your dose looks like here. Individual results vary.

Here is the mindset shift. During the losing phase, progress is loud. The scale drops, clothes fit differently, people notice. Maintenance is quiet. Nothing dramatic happens, and that silence makes people nervous. They wonder if it is still working. It is. Holding steady after losing weight is, clinically, a real result.

Does maintenance mean I am cured?

No. Maintenance means your weight has stabilized, not that the condition behind it has resolved. The biology that made losing weight hard does not switch off because you reached a number. That is why physicians frame GLP-1 treatment as ongoing care for a chronic condition, similar to how blood pressure medication is managed. Your plan is reviewed in follow-up, not set once and forgotten.

Think of it like a thermostat. Your body has a setpoint it wants to defend. The medication helps hold the dial where you set it. Take the dial away, and the body tends to drift back toward where it started.

What happens if you stop, and why timing matters

If you stop a GLP-1 medication, weight often returns over the following months. In the STEP 1 trial extension, participants who came off semaglutide regained about two-thirds of the weight they had lost within one year.¹ They still stayed below their starting weight, but the trend was clear. Individual results vary, and any decision to stop belongs in a conversation with your physician.

This is the part most people are not warned about. The medication does not "teach" your body a new normal that holds on its own. It actively manages appetite signals and the setpoint while you take it. Remove it, and those signals often return.

How much weight comes back after stopping?

Studies show meaningful regain after stopping. The STEP 1 extension found roughly two-thirds of lost weight returned within a year off semaglutide.¹ Individual results vary. The takeaway is not "never stop." It is "stopping is a medical decision with a predictable pattern, so plan it with your physician."

Can I lower my dose instead of stopping?

That is a physician decision, not a self-directed one. Some people stay on a steady dose during maintenance. Others discuss adjustments with their physician based on how their body responds. The key rule: titration up or down is managed by your prescriber, never improvised at home. If a provider hands you a plan to change your own dose without follow-up, treat that as a red flag.

Muscle is the maintenance variable nobody mentions

When you lose weight, some of what you lose is lean mass, not just fat. Without intervention, lean mass can make up a meaningful share of total loss. In maintenance, protecting muscle matters more than ever, because muscle supports metabolism and day-to-day strength. The good news: protein and resistance training help preserve it. Individual results vary.

A 2026 Cell Reports Medicine analysis found that GLP-1 weight loss does not cause a disproportionate loss of muscle relative to fat, and that body composition can actually improve, with muscle making up a higher share of body weight after treatment.² Still, "not disproportionate" is not "nothing." Two habits move the needle.

• Protein. A research review linked intakes above 1.3 grams per kilogram of body weight a day with better muscle preservation.³
• Resistance training. The same review links strength work to preserving lean mass during treatment.³

For the deeper version, see our guide on preserving muscle on a GLP-1.

Why does muscle matter in maintenance specifically?

Because muscle is metabolically active tissue. More lean mass generally supports a higher resting metabolism, which makes holding your weight easier over time. Losing muscle during the losing phase and then ignoring it in maintenance can make the steady state harder to keep. Protein and resistance training are the two levers most within your control. Your physician can help you set realistic targets.

Active loss vs maintenance, at a glance

The 2026 backdrop: cost, policy, and your plan

Staying on treatment long-term raises a fair question: can I afford this, and is the supply stable? Two 2026 shifts matter. Federal pricing programs lowered some list prices, and a Medicare bridge program begins July 2026. Separately, the FDA proposed changes to large-scale compounding. None of this changes the core point: maintenance is a long-term plan, so the economics matter. Individual results vary.

On coverage, the Medicare GLP-1 Bridge begins July 1, 2026 and runs through December 31, 2027, offering eligible beneficiaries a flat $50 monthly copay on certain GLP-1 medications.^4,5 Cost remains a real barrier for many people who take these medications.⁵

Does the FDA compounding news affect my maintenance plan?

For most patients on a patient-specific prescription, the headline does not change your plan. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, citing no clinical need now that shortages have resolved. That proposal targets large-scale 503B outsourcing compounding. It does not touch 503A pharmacies preparing a medication under a patient-specific prescription. Public comment closed June 29, 2026.⁶

What that means in plain terms: a compounded GLP-1 medication prepared by a state-licensed 503A pharmacy under a patient-specific prescription is a different lane from the 503B bulk supply the FDA proposal addresses. If you are on treatment through a provider that works this way, the proposal is not a reason to panic. It is a reason to ask your provider where your medication comes from.

What should a good provider give you in maintenance?

A good maintenance provider keeps physician follow-up included, shows you the full recurring cost before charging your card, and lets you cancel without a phone call. They explain where your medication is prepared. They do not vanish once the weight is off. That last part, post-prescription support, is exactly where most telehealth brands quietly drop the ball. If the brand you choose cannot promise ongoing follow-up, keep looking. (This is the standard sipra was built around. Here is how that support works.)

Where to go from here

Maintenance is quieter than losing, but it is not passive. Here is where to start.

1. Keep your follow-up. Do not treat reaching your goal as a reason to skip appointments. Your physician manages your dose and monitors how you respond. For a sense of what good ongoing care looks like, see support after your prescription.
2. Protect muscle. Hit your protein target and add resistance training. Start with preserving muscle on a GLP-1.
3. Pick a provider that stays. Demand included follow-up, full cost disclosure before checkout, and easy cancellation.

For the broader picture of what to expect over time, our hub on realistic GLP-1 results ties it together, along with maintenance mode and GLP-1 progress beyond the scale.